Case Scenario to Guide Second-Line Treatment Selection A 52-year-old man with a three-year history of T2DM presents for a review
Efficacy and safety of monotherapy with the novel sodium/glucose cotransporter-2 inhibitor Tofogliflozin in Japanese patients with type 2 diabetes mellitus: a combined phase 2 and 3 randomized, placebo-controlled, double-blind, parallel-group comparative study
I think the analysis could benefit from a comparison of healthcare costs between a control group of obese and morbidly obese patients by an age cohort race ethnicity and gender vs those with a healthy weight as background over time
(1974) Methylation of purines and nicotinamide in the rat by dichlorvos
Ozempic offers doses from 0.25 mg to 2.0 mg, while Mounjaro pens are single-use and range from 2.5 mg to 15 mg, depending on your prescription
This 22% decrease in MACE is an absolute decrease of 1.8% - meaning that If 1000 people are treated, 18 cases of MACE will be prevented